Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Statistical Methods in Medical Research|May 16, 2017
Modeling qRT-PCR dynamics with application to cancer biomarker quantificationInna Chervoneva, Boris Freydin, Terry Hyslop, et al.
Bioinformatics (Oxford, England)|December 4, 2020
Quantification of spatial tumor heterogeneity in immunohistochemistry staining imagesInna Chervoneva, Amy R Peck, Misung Yi, et al.
The Annals of Applied Statistics|April 9, 2021
Estimation of nonlinear differential equation model for glucose-insulin dynamics in type I diabetic patients using generalized smoothingInna Chervoneva, Boris Freydin, Brian Hipszer, et al.
Breast Cancer Research and Treatment|November 20, 2010
Increased SIAH expression predicts ductal carcinoma in situ (DCIS) progression to invasive carcinomaKathryn C Behling, Amy Tang, Boris Freydin, et al.
Cancer Biology & Therapy|June 25, 2010
Stromal CD10 and SPARC expression in ductal carcinoma in situ (DCIS) patients predicts disease recurrenceAgnieszka K Witkiewicz, Boris Freydin, Inna Chervoneva, et al.
Cancer|November 17, 2011
Epidermal growth factor receptor and insulinlike growth factor 1 receptor expression predict poor survival in pancreatic ductal adenocarcinomaMatias E Valsecchi, Mary McDonald, Jonathan R Brody, et al.
Annals of Surgery|August 27, 2010
HuR status is a powerful marker for prognosis and response to gemcitabine-based chemotherapy for resected pancreatic ductal adenocarcinoma patientsNathan G Richards, David W Rittenhouse, Boris Freydin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 18, 2016
Validation of tumor protein marker quantification by two independent automated immunofluorescence image analysis platformsAmy R Peck, Melanie A Girondo, Chengbao Liu, et al.
Breast Cancer Research : BCR|September 6, 2013
Prolactin-Stat5 signaling in breast cancer is potently disrupted by acidosis within the tumor microenvironmentNing Yang, Chengbao Liu, Amy R Peck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2011
Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failureAmy R Peck, Agnieszka K Witkiewicz, Chengbao Liu, et al.
Pageof 2